iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA)
IDNA is a passive ETF by iShares tracking the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. IDNA launched on Jun 11, 2019 and has a 0.47% expense ratio.
ETF Info
- ISINUS46435U1925
- CUSIP46435U192
- IssueriShares
- Inception DateJun 11, 2019
- RegionNorth America (U.S.)
- CategoryHealth & Biotech Equities
- Expense Ratio0.47%
- Index TrackedNYSE FactSet Global Genomics and Immuno Biopharma Index
- Asset ClassEquity
Asset Class Size
Multi-CapAsset Class Style
Blend
Trading Data
- Previous Close$29.02
- Year Range$26.66 - $55.15
- EMA (50)$31.58
- EMA (200)$39.41
- Average Volume$54.54K
IDNAShare Price Chart
Click Calculate to get results
IDNAPerformance
The chart shows the growth of $10,000 invested in iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund on Jun 14, 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $11,858 for a total return of roughly 18.58%. All prices are adjusted for splits and dividends.
IDNAReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | -11.55% | -12.57% |
| YTD | -33.76% | -18.14% |
| 6M | -38.76% | -17.07% |
| 1Y | -35.34% | -5.21% |
| 5Y | 5.97% | 10.72% |
| 10Y | 5.97% | 10.72% |
IDNAMonthly Returns Heatmap
Click Calculate to get results
IDNADividend History
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund granted a 1.06% dividend yield in the last twelve months, as of May 21, 2022. The annual payout for that period amounted to $0.31 per share.
| Period | TTM | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Dividend | $0.31 | $0.31 | $0.12 | $0.24 |
Dividend yield | 1.06% | 0.70% | 0.26% | 0.81% |
IDNADrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
IDNAWorst Drawdowns
The table below shows the maximum drawdowns of the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund is 51.66%, recorded on May 11, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -51.66% | Sep 3, 2021 | 173 | May 11, 2022 | — | — | — |
| -26.93% | Mar 5, 2020 | 8 | Mar 16, 2020 | 23 | Apr 17, 2020 | 31 |
| -22.23% | Feb 9, 2021 | 19 | Mar 8, 2021 | 107 | Aug 9, 2021 | 126 |
| -14.38% | Jul 19, 2019 | 58 | Oct 9, 2019 | 30 | Nov 20, 2019 | 88 |
| -13.58% | Jul 21, 2020 | 35 | Sep 8, 2020 | 23 | Oct 9, 2020 | 58 |
| -9.93% | Oct 14, 2020 | 13 | Oct 30, 2020 | 19 | Nov 27, 2020 | 32 |
| -9.34% | Dec 26, 2019 | 25 | Jan 31, 2020 | 22 | Mar 4, 2020 | 47 |
| -8.3% | Dec 23, 2020 | 6 | Dec 31, 2020 | 9 | Jan 14, 2021 | 15 |
| -7.52% | Aug 10, 2021 | 8 | Aug 19, 2021 | 10 | Sep 2, 2021 | 18 |
| -7.36% | May 19, 2020 | 17 | Jun 11, 2020 | 7 | Jun 22, 2020 | 24 |
IDNAVolatility Chart
Current iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund volatility is 54.64%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.
Portfolios with iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
Loading data...